drugset / Trial / NCT01813162
In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products
RandomizedCrossoverOpen-label
Summary
The purpose of the study is determine if the local release characteristics and systemic exposure to tenofovir (TFV) 1% gel and a given commonly used vaginal product are impacted by concomitant use
Timeline
- Start
- 2013-12
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etonogestrel | Unknown | — | Other |
| Subject | Metronidazole | Small molecule | 37.5 mg | Other |
| Subject | Tenofovir | Small molecule | 4.4 g | Other |
| Subject | Terconazole | Small molecule | 20 mg | Other |
| Subject | ethinyl estradiol | Small molecule | — | Other |
Indications
No indication recorded.